AFL Share Price | Aflac, Inc. Stock Analysis & Recommendation

Q: How big is Aflac, Inc.?

As of Jun 18, Aflac, Inc. has a market capitalization of 125,610.51 million, categorizing it as a Large Cap company.As of Jun 18, the sum of Net Sales for the latest four quarters is 0.00 million, while the sum of Net Profit for the same period is 3,593.00 million.As of Dec 24, the reporting period shows Shareholder's Funds at 26,098.00 million and Total Assets at 117,403.00 million.

Q: What does Aflac, Inc. do?

Overview:Aflac, Inc. is a business holding company involved in supplemental health and life insurance, operating within the insurance industry and categorized as a large-cap company.Financial Snapshot:- Net Profit: 29 Million (Quarterly Results - Mar 2025)- Market Cap: USD 125,610.51 Million (Large Cap)Key Metrics:- P/E: 36.00- Dividend Yield: 1.02%- Debt Equity: -999,999.00- Return on Equity: 13.64%- Price to Book: 4.77Contact Details:- Address: 1932 WYNNTON RD, COLUMBUS GA: 31999- Tel: 1 706 3233431- Website: https://www.aflac.com/

Q: Who are in the management team of Aflac, Inc.?

As of March 2022, the management team of Aflac, Inc. includes the following members:- Mr. Daniel Amos: Chairman of the Board, Chief Executive Officer- Mr. W. Paul Bowers: Lead Independent Director- Mr. Toshihiko Fukuzawa: Independent Director- Mr. Thomas Kenny: Independent Director- Ms. Georgette Kiser: Independent Director- Mrs. Karole Lloyd: Independent DirectorThis team plays a crucial role in guiding the company's strategic direction and governance.

Q: Is Aflac, Inc. overvalued or undervalued?

As of 5 August 2025, the valuation grade for Aflac, Inc. has moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company is overvalued based on its current metrics, with a P/E ratio of 36, a Price to Book Value of 4.84, and an EV to Capital Employed ratio of 4.75. In comparison, Progressive Corp. has a P/E of 18.83 and MetLife, Inc. has a P/E of 18.69, both indicating that Aflac is trading at a premium relative to its peers.Despite a strong performance over the long term, with a 5-year return of 185.71% compared to the S&P 500's 96.61%, Aflac's recent returns have lagged behind the index, particularly in the 1-year period where it returned -0.88% versus the S&P 500's 17.14%. This suggests that while the company has historically performed well, its current valuation may not be justified given its recent performance and comparison to industry peers.

Q: Is Aflac, Inc. technically bullish or bearish?

As of 12 September 2025, the technical trend for Aflac, Inc. has changed from sideways to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bearish, indicating mixed signals across different time frames. The Bollinger Bands show a mildly bullish stance on the weekly chart and a bullish stance on the monthly chart. Moving averages indicate a mildly bearish trend on the daily chart. Dow Theory supports a mildly bullish trend on both weekly and monthly time frames. In terms of performance, Aflac has underperformed the S&P 500 over the past year with a return of -0.88% compared to the S&P 500's 17.14%, but it has outperformed over the 3-year and 5-year periods. Overall, the current technical stance is mildly bullish, driven primarily by the weekly MACD and Bollinger Bands.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

1.65 M

Shareholding (Dec 2025)

FII

23.29%

Held by 365 FIIs

DII

45.77%

Held by 61 DIIs

Promoter

9.99%

How big is Aflac, Inc.?

22-Jun-2025

As of Jun 18, Aflac, Inc. has a market capitalization of $125.61 billion, with net profit of $3.59 billion over the last four quarters and total assets of $117.40 billion.

View full answer

What does Aflac, Inc. do?

22-Jun-2025

Aflac, Inc. is a large-cap holding company specializing in supplemental health and life insurance. As of March 2025, it has a market cap of approximately $125.61 billion and reported a net profit of $29 million.

View full answer

Who are in the management team of Aflac, Inc.?

22-Jun-2025

As of March 2022, Aflac, Inc.'s management team includes Chairman and CEO Daniel Amos, Lead Independent Director W. Paul Bowers, and Independent Directors Toshihiko Fukuzawa, Thomas Kenny, Georgette Kiser, and Karole Lloyd, who collectively guide the company's strategic direction and governance.

View full answer

Is Aflac, Inc. overvalued or undervalued?

20-Sep-2025

As of August 5, 2025, Aflac, Inc. is considered very expensive with a high P/E ratio of 36 and other valuation metrics indicating overvaluation compared to peers like Progressive Corp. and MetLife, despite its strong long-term performance.

View full answer

Is Aflac, Inc. technically bullish or bearish?

20-Sep-2025

As of September 12, 2025, Aflac, Inc. shows a mildly bullish trend with mixed signals from MACD and moving averages, having underperformed the S&P 500 over the past year but outperformed in the 3- and 5-year periods.

View full answer

Compare Aflac, Inc. with Similar Stocks

MetLife, Inc.Progressive Corp.American International Group, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 17.89%

The company declared negative results in Mar'25 after positive results in Dec'24

With ROE of 13.64%, it has a expensive valuation with a 4.84 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Insurance

Market cap

USD 131,599 Million (Large Cap)

P/E

36.00

Industry P/E

Dividend Yield

0.79%

Debt Equity

-999,999.00

Return on Equity

16.99%

Price to Book

6.13

Revenue and Profits:

Net Sales:

(Quarterly Results - Dec 2025)

Net Profit:

1,379 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-0.89%

6 Months

0.27%

1 Year

1.03%

2 Years

29.81%

3 Years

78.69%

4 Years

74.12%

5 Years

111.96%

Aflac, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-5.00%

EBIT Growth (5y)

EBIT to Interest (avg)

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

18.17%

Dividend Payout Ratio

34.02%

Pledged Shares

Institutional Holding

70.44%

ROCE (avg)

ROE (avg)

17.89%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

6.13

EV to EBIT

EV to EBITDA

EV to Capital Employed

5.66

EV to Sales

7.81

PEG Ratio

Dividend Yield

0.79%

ROCE (Latest)

ROE (Latest)

16.99%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Sideways

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Mildly Bearish

Dow Theory

No Trend

Bullish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 142 Schemes (20.95%)

Foreign Institutions

Held by 365 Foreign Institutions (23.29%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Sep 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -15.86% vs 173.62% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "61.00",
          "val2": "57.00",
          "chgp": "7.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,379.00",
          "val2": "1,639.00",
          "chgp": "-15.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "335.60%",
          "val2": "432.70%",
          "chgp": "-9.71%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -33.01% vs 16.83% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "36.00",
          "val2": "40.00",
          "chgp": "-10.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "220.00",
          "val2": "197.00",
          "chgp": "11.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,646.00",
          "val2": "5,443.00",
          "chgp": "-33.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "276.90%",
          "val2": "349.40%",
          "chgp": "-7.25%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

0.00

Interest

61.00

57.00

7.02%

Exceptional Items

0.00

Consolidate Net Profit

1,379.00

1,639.00

-15.86%

Operating Profit Margin (Excl OI)

335.60%

432.70%

-9.71%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -15.86% vs 173.62% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

36.00

40.00

-10.00%

Interest

220.00

197.00

11.68%

Exceptional Items

0.00

Consolidate Net Profit

3,646.00

5,443.00

-33.01%

Operating Profit Margin (Excl OI)

276.90%

349.40%

-7.25%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -33.01% vs 16.83% in Dec 2024

All Annual Results

Company CV

About Aflac, Inc.

Aflac, Inc.

Insurance

Aflac Incorporated is a business holding company. The Company is involved in supplemental health and life insurance, which is marketed and administered through its subsidiary, American Family Life Assurance Company of Columbus (Aflac). The Company's insurance business consists of two segments: Aflac Japan and Aflac U.S. The Company designs the United States insurance products to provide supplemental coverage for people having medical or primary insurance coverage. Aflac U.S. offers accident coverage on both an individual and group basis. The Company offers cancer plans, critical illness plans, and critical care and recovery plans. The Company designs the United States insurance products to provide supplemental coverage for people having medical or primary insurance coverage. Aflac U.S. offers accident coverage on both an individual and group basis. The Company offers cancer plans, critical illness plans, and critical care and recovery plans.

Company Coordinates

Company Details

1932 WYNNTON RD , COLUMBUS GA : 31999

Tel: 1 706 3233431

https://www.aflac.com/

Registrar Details